By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 10 February 2023 Tomas Roos defends his thesis 17 February 2023. The aggregation of the protein Amyloid-beta (Abeta) into plaques outside the nerve cells has been recognized in patients with Alzheimer’s disease since 1905. But eliminating the plaques has not helped patients so far. Still, Tomas Roos thinks that Abe

https://www.multipark.lu.se/article/does-alzheimers-disease-start-inside-neurons-phd-interview-tomas-roos - 2025-07-15

By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 28 February 2023 The milestone transplant was performed at Skåne University Hospital in February. On 13th of February, a transplant of stem cell-derived nerve cells was administered to a person with Parkinson’s at Skåne University Hospital, Sweden. The product has been developed by Lund University and it is now being tested in

https://www.multipark.lu.se/article/first-patient-receives-milestone-stem-cell-based-transplant-parkinsons-disease - 2025-07-15

By press [at] liu [dot] se (Mikael Sönne) - published 8 March 2023 With the injectable gel the researchers were able to grow electrodes in living tissue. Here it is tested on a microfabricated circuit. Photo: Thor Balkhed/Linköpings universitet The boundaries between biology and technology are becoming blurred. Researchers at Linköping, Lund, and Gothenburg universities in Sweden have successfully

https://www.multipark.lu.se/article/electrodes-grown-brain - 2025-07-15

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 20 March 2023 Kajsa Brolin defends her thesis 27 March 2023. Photo: Kennet Ruona Kajsa Brolin explores how our genes and environment affect the risk of developing Parkinson’s disease. March 27, she defends her Ph.D. project partly based on MultiPark’s biobank sample collection. Here, she tells about the newly disco

https://www.multipark.lu.se/article/genes-and-environment-pd-phd-interview-kajsa-brolin - 2025-07-15

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 13 March 2023 After a decade of protocol development and preparations, MultiPark researchers have finally launched the clinical trial. Recently, dopamine-producing cells generated from embryonic stem cells were transplanted into the first Parkinson's patient at Skåne University Hospital. During the autumn 2022, the

https://www.multipark.lu.se/article/stem-pd-bench-bedside-story-multipark-researchers-0 - 2025-07-15

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 16 March 2023 Looking for the next step in your career? In need of some scientific inspiration? Or are you just curious about what MultiPark´s senior researchers are doing and their professional journey? Listen to MultiPark’s new podcast series “Meet our scientists”! In a newly launched podcast, young MultiPark res

https://www.multipark.lu.se/article/meet-our-scientists-new-podcast-young-multipark-researchers - 2025-07-15

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 11 April 2023 Behind the ongoing clinical trials are years of basic research in the lab where the new generation of researchers continues where the previous one handed over. Photo: Kenneth Ruona. In the early 1950s, no one knew what caused Parkinson's disease. Then, Arvid Carlsson's discovery of dopamine opened the

https://www.multipark.lu.se/article/world-parkinsons-day-transplantations-parkinsons-disease-time-travel - 2025-07-15

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 28 March 2023 Genetics are one of the keys to understanding neurodegenerative disease. That is why MultiPark researchers with expertise in genetics gather across research groups. Genetics of neurodegenerative diseases is a new special interest group (SIG) addressing scientific and technological needs to unravel the

https://www.multipark.lu.se/article/genetics-neurodegenerative-diseases-special-interest-group - 2025-07-15

By katrin [dot] stahl [at] med [dot] lu [dot] se (Lund University) - published 13 April 2023 Sara Linse and Oskar Hansson. Three researchers at Lund University, all with a long list of significant research credentials, have been awarded the ERC Advanced Grant worth EUR 2.5 million each to further develop and advance their research projects. Two of them are MultiPark research leaders. They do resea

https://www.multipark.lu.se/article/double-success-multipark-research-groups-prestigious-eu-grant-round - 2025-07-15

By asa [dot] hansdotter [at] med [dot] lu [dot] se (Åsa Hansdotter) - published 17 May 2023 Several Nobel laureates, renowned scientists, and successful biotech entrepreneurs are coming to Lund in May to participate in the Lund Spring Symposium, an international pharmaceutical symposium sponsored by MultiPark. Sarah Tabrizi, a high profile Huntington researcher, and some of MultiPark's own researc

https://www.multipark.lu.se/article/superstars-coming-lund-pharmaceutical-symposium-sponsored-multipark - 2025-07-15

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 29 May 2023 A 7 Tesla MRI of a human brain. Picture: Tekla Kylkilahti, Lundgaard group. Recent studies indicate that acquired brain injuries, such as traumatic brain injury, trigger potentially harmful responses that may lead to neurodegenerative pathology. “Acquired brain injuries and their links to neurodegenerat

https://www.multipark.lu.se/article/acquired-brain-injuries-special-interest-group - 2025-07-15

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 7 June 2023 Thanks to the recent development of diagnostic tools based on blood biomarkers linked to Alzheimer’s, it is possible to predict whether an individual will develop the disease. Therefore, MultiPark researchers gather across groups to investigate hidden opportunities and develop implementable tools also f

https://www.multipark.lu.se/article/fluid-biomarkers-special-interest-group - 2025-07-15

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 2 June 2023 Microglial immune cells around the area of a human embryonic stem cell transplant to treat Parkinson’s Disease in a rat brain. In April, the young MultiPark working group organized a photo competition entitled "Brain in Picture". The external jury has had a hard time choosing, but now, they have appoint

https://www.multipark.lu.se/article/brain-picture-winning-photo - 2025-07-15

By alexis [dot] bento_luis [at] med [dot] lu [dot] se (Alexis Luis) - published 27 June 2023 Postdoctoral researcher Vivien Horvath investigates X-Linked Dystonia-Parkinsonism (XDP), a rare neurodegenerative disorder. New research is underway at Lund University, led by Dr. Vivien Horvath, a postdoctoral researcher at Lund Stem Cell Center. Supported by a new grant from the Collaborative Center for

https://www.multipark.lu.se/article/exploring-role-jumping-genes-x-linked-dystonia-parkinsonism - 2025-07-15

By alexis [dot] bento_luis [at] med [dot] lu [dot] se (Alexis Luis) - published 5 July 2023 Fredrik Nilsson defended his thesis on 10 May 2023. Fredrik Nilsson defended his Ph.D. thesis on May 10, 2023. For the last four years, he has explored the use of patient-specific cells in cell replacement therapy for Parkinson's disease to identify strategies to safeguard these transplanted cells from dise

https://www.multipark.lu.se/article/cell-replacement-therapy-parkinsons-disease-phd-interview-fredrik-nilsson - 2025-07-15

By Olle [dot] dahlback [at] med [dot] lu [dot] se (Olle Dahlbäck) - published 17 February 2021 A recent study indicates that there is a correlation between the number of people spend on the internet and problematic and addictive games. Photo: Mostphotos Low age, the number of hours spent on the internet/social media, feelings of loneliness and thoughts about seeking treatment for mental illness. A

https://www.medicine.lu.se/article/study-screen-games-mental-illness-and-addiction - 2025-07-15

By Agata [dot] Garpenlind [at] med [dot] lu [dot] se (Agata Garpenlind) - published 3 March 2021 Mikael Dolsten, the celebrated head of research at Pfizer and visiting professor of Pharmacology at the Faculty of Medicine, tells the story of how his company developed a COVID-19 vaccine in just nine months. Photo: Agata Garpenlind. It’s Friday night in Lund and soon Mikael Dolsten, acclaimed head of

https://www.medicine.lu.se/article/our-visiting-professor-tells-astonishing-story-vaccine-can-save-world-pandemic - 2025-07-15

By olle [dot] dahlback [at] med [dot] lu [dot] se (Olle Dahlbäck) - published 15 March 2021 Lars Edvinsson. Foto: Tove Smeds In the early 1970s, Lars Edvinsson stepped through the doors of Lund University for the first time. More than 50 years later, he is awarded the world's most prominent prize in brain research, "The Brain Prize", which is awarded annually by the Lundbeck Foundation. He receive

https://www.medicine.lu.se/article/migraine-pioneer-awarded-prestigious-brain-prize - 2025-07-15

By asa [dot] hansdotter [at] med [dot] lu [dot] se (Åsa Hansdotter) - published 15 March 2021 The structure of an antibody. In recent years, therapeutic antibodies have transformed the treatment of cancer and autoimmune diseases. Now, researchers at Lund University in Sweden have developed a new, efficient method based on the genetic scissors CRISPR-Cas9, that facilitates antibody development. The

https://www.medicine.lu.se/article/new-method-facilitates-development-antibody-based-drugs - 2025-07-15

Published 27 March 2021 Jan Sundquist, Professor at the Center for Primary Health Care Research, a collaboration between Lund University and Region Skåne, has been awarded a $3 million grant by the National Institutes of Health, NIH, USA. The grant is awarded for research of heredity and the importance of the environment regarding the opioid epidemic and other drug abuse. Together with Professor K

https://www.medicine.lu.se/article/opioid-epidemic-and-other-drug-abuse - 2025-07-15